Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy

E-ISSN： 1873-4316|12|4|570-594

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.12, Iss.4, 2011-04, pp. : 570-594

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 4, 2011-04 ,pp. : 609-620

Bentham Science Publishers

Access to resources Recommend Favorite

An Update on Overcoming MDR1-Mediated Multidrug Resistance in Cancer Chemotherapy

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 273-286

Bentham Science Publishers

Access to resources Recommend Favorite

Multi-drug resistance and cancer

By Atalay Can

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 5, 2007-05 ,pp. : 511-520

Informa Healthcare

Access to resources Recommend Favorite

Human Multidrug Transporter ABCG2, a Target for Sensitizing Drug Resistance in Cancer Chemotherapy

Current Medicinal Chemistry, Vol. 14, Iss. 6, 2007-03 ,pp. : 689-701

Bentham Science Publishers

Access to resources Recommend Favorite

Celecoxib Upregulates Multidrug Resistance Proteins in Colon Cancer: Lack of Synergy with Standard Chemotherapy

Current Cancer Drug Targets, Vol. 8, Iss. 5, 2008-08 ,pp. : 414-420

Bentham Science Publishers

Access to resources Recommend Favorite